Literature DB >> 11884618

RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.

Ulrich Hermanto1, Cong S Zong, Weiqun Li, Lu-Hai Wang.   

Abstract

The insulin-like growth factor I (IGF-I) receptor (IGF-IR) is known to regulate a variety of cellular processes including cell proliferation, cell survival, cell differentiation, and cell transformation. IRS-1 and Shc, substrates of the IGF-IR, are known to mediate IGF-IR signaling pathways such as those of mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K), which are believed to play important roles in some of the IGF-IR-dependent biological functions. We used the cytoplasmic domain of IGF-IR in a yeast two-hybrid interaction trap to identify IGF-IR-interacting molecules that may potentially mediate IGF-IR-regulated functions. We identified RACK1, a WD repeat family member and a Gbeta homologue, and demonstrated that RACK1 interacts with the IGF-IR but not with the closely related insulin receptor (IR). In several types of mammalian cells, RACK1 interacted with IGF-IR, protein kinase C, and beta1 integrin in response to IGF-I and phorbol 12-myristate 13-acetate stimulation. Whereas most of RACK1 resides in the cytoskeletal compartment of the cytoplasm, transformation of fibroblasts and epithelial cells by v-Src, oncogenic IR or oncogenic IGF-IR, but not by Ros or Ras, resulted in a significantly increased association of RACK1 with the membrane. We examined the role of RACK1 in IGF-IR-mediated functions by stably overexpressing RACK1 in NIH 3T3 cells that expressed an elevated level of IGF-IR. RACK1 overexpression resulted in reduced IGF-I-induced cell growth in both anchorage-dependent and anchorage-independent conditions. Overexpression of RACK1 also led to enhanced cell spreading, increased stress fibers, and increased focal adhesions, which were accompanied by increased tyrosine phosphorylation of focal adhesion kinase and paxillin. While IGF-I-induced activation of IRS-1, Shc, PI3K, and MAPK pathways was unaffected, IGF-I-inducible beta1 integrin-associated kinase activity and association of Crk with p130(CAS) were significantly inhibited by RACK1 overexpression. In RACK1-overexpressing cells, delayed cell cycle progression in G(1) or G(1)/S was correlated with retinoblastoma protein hypophophorylation, increased levels of p21(Cip1/WAF1) and p27(Kip1), and reduced IGF-I-inducible Cdk2 activity. Reduction of RACK1 protein expression by antisense oligonucleotides prevented cell spreading and suppressed IGF-I-dependent monolayer growth. Our data suggest that RACK1 is a novel IGF-IR signaling molecule that functions as a positive mediator of cell spreading and contact with extracellular matrix, possibly through a novel IGF-IR signaling pathway involving integrin and focal adhesion signaling molecules.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884618      PMCID: PMC133698          DOI: 10.1128/MCB.22.7.2345-2365.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  69 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

2.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein.

Authors:  X J Sun; P Rothenberg; C R Kahn; J M Backer; E Araki; P A Wilden; D A Cahill; B J Goldstein; M F White
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

Review 3.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

4.  The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform.

Authors:  S J Yarwood; M R Steele; G Scotland; M D Houslay; G B Bolger
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

5.  C-terminal Src kinase associates with ligand-stimulated insulin-like growth factor-I receptor.

Authors:  C Arbet-Engels; S Tartare-Deckert; W Eckhart
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

Review 6.  Focal adhesion kinase in integrin-mediated signaling.

Authors:  L A Cary; J L Guan
Journal:  Front Biosci       Date:  1999-01-15

7.  Opposite regulation of tyrosine-phosphorylation of p130(Cas) by insulin and insulin-like growth factor I.

Authors:  T Fujita; H Maegawa; A Kashiwagi; H Hirai; R Kikkawa
Journal:  J Biochem       Date:  1998-12-01       Impact factor: 3.387

8.  The function of GRB2 in linking the insulin receptor to Ras signaling pathways.

Authors:  E Y Skolnik; A Batzer; N Li; C H Lee; E Lowenstein; M Mohammadi; B Margolis; J Schlessinger
Journal:  Science       Date:  1993-06-25       Impact factor: 47.728

9.  Enhancement of transforming potential of human insulinlike growth factor 1 receptor by N-terminal truncation and fusion to avian sarcoma virus UR2 gag sequence.

Authors:  D Liu; W J Rutter; L H Wang
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

Authors:  A S Zervos; J Gyuris; R Brent
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

View more
  72 in total

1.  The RNA-binding protein SERBP1 interacts selectively with the signaling protein RACK1.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2017-03-04       Impact factor: 4.315

2.  PKB phosphorylation and survivin expression are cooperatively regulated by disruption of microfilament cytoskeleton.

Authors:  Yu-Long Liang; Li-Ying Wang; Heng Wu; Dong-Zhu Ma; Zhen Xu; Xi-Liang Zha
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

3.  RACK1 regulates G1/S progression by suppressing Src kinase activity.

Authors:  Vidya Mamidipudi; Jian Zhang; Kelly C Lee; Christine A Cartwright
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 4.  Working hard at the nexus between cell signaling and the ribosomal machinery: An insight into the roles of RACK1 in translational regulation.

Authors:  Simone Gallo; Nicola Manfrini
Journal:  Translation (Austin)       Date:  2015-11-23

5.  RACK1 regulates Src activity and modulates paxillin dynamics during cell migration.

Authors:  Ashley T Doan; Anna Huttenlocher
Journal:  Exp Cell Res       Date:  2007-05-18       Impact factor: 3.905

6.  FES-related tyrosine kinase activates the insulin-like growth factor-1 receptor at sites of cell adhesion.

Authors:  Joanna Stanicka; Leonie Rieger; Sandra O'Shea; Orla Cox; Michael Coleman; Ciara O'Flanagan; Barbara Addario; Nuala McCabe; Richard Kennedy; Rosemary O'Connor
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

7.  Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway.

Authors:  Dong Hoon Shin; Hyo-Jong Lee; Hye-Young Min; Sun Phil Choi; Mi-Sook Lee; Jung Weon Lee; Faye M Johnson; Kapil Mehta; Scott M Lippman; Bonnie S Glisson; Ho-Young Lee
Journal:  J Natl Cancer Inst       Date:  2013-10-03       Impact factor: 13.506

8.  RACK1 mediates activation of JNK by protein kinase C [corrected].

Authors:  Pablo López-Bergami; Hasem Habelhah; Anindita Bhoumik; Weizhou Zhang; Lu-Hai Wang; Ze'ev Ronai
Journal:  Mol Cell       Date:  2005-08-05       Impact factor: 17.970

9.  Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma.

Authors:  Zhi Wang; Lu Jiang; Canhua Huang; Zhengyu Li; Lijuan Chen; Lantu Gou; Ping Chen; Aiping Tong; Minghai Tang; Feng Gao; Jun Shen; Yuanyuan Zhang; Jingping Bai; Min Zhou; Di Miao; Qianming Chen
Journal:  Mol Cell Proteomics       Date:  2008-05-04       Impact factor: 5.911

Review 10.  IGF-I receptor, cell-cell adhesion, tumour development and progression.

Authors:  Loredana Mauro; Eva Surmacz
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.